GeoVax Labs, Inc.(GOVX)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $4.0M in revenue.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
GOVX Stock Analysis & AI Quality Score
AI stock analysis and institutional research for GeoVax Labs, Inc. (GOVX), a Healthcare sector company. GOVX is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $4.0m in revenue. Based on the latest XBRL financial filings (Q1 2026), GeoVax Labs, Inc. reports net income of $-5.3M, free cash flow of $-3.5M. Top institutional holders of GOVX by reported 13-F value include ARMISTICE CAPITAL,, GEODE CAPITAL MANAGEMENT,, VANGUARD FIDUCIARY CO, based on the most recent SEC filings. GOVX trades on the Nasdaq exchange and files with the SEC under CIK 832489. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate GOVX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for GeoVax Labs, Inc. directly from SEC EDGAR.
Revenue
Q1 2026
$0.00
Net Income
Q1 2026
$-5.3M
Free Cash Flow
Q1 2026
$-3.5M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
-37.1% YoYNet Income
+14.1% YoYOperating Income
+13.9% YoYTotal Assets
-22.2% YoYOp. Cash Flow
+13.0% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $2.5M -37.1% | $4.0M | $0.00 -100.0% | $81.5K -78.9% | $385.5K -78.9% | $1.8M |
| Net Income | $-21.5M +14.1% | $-25.0M +3.8% | $-26.0M -85.2% | $-14.0M +24.5% | $-18.6M -527.8% | $-3.0M |
| Operating Income | $-21.6M +13.9% | $-25.1M +6.0% | $-26.7M -90.6% | $-14.0M +25.2% | $-18.7M -565.5% | $-2.8M |
| Total Assets | $6.3M -22.2% | $8.2M -12.1% | $9.3M -70.4% | $31.3M +165.7% | $11.8M +13.5% | $10.4M |
| Operating Cash Flow | $-21.5M +13.0% | $-24.7M +2.0% | $-25.2M -32.3% | $-19.0M -70.0% | $-11.2M -307.1% | $-2.8M |
AI Insight: GOVX Ratio Trends
Insufficient data: all financial ratios are missing across the entire period.
• No operating margin, net profit margin, ROE, ROA, ROIC, or debt-to-equity figures available for any quarter from Q2 2024 through Q1 2026.
⚠ Complete absence of ratio data prevents assessment of profitability trends, capital efficiency, or leverage trajectory.
Get alerted when GOVX's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for GeoVax Labs, Inc. including:
Top Institutional Holders of GOVX
ARMISTICE CAPITAL, LLC
$371.6K269,253 shGEODE CAPITAL MANAGEMENT, LLC
$49.8K36,076 shVANGUARD FIDUCIARY TRUST CO
$7.0K5,068 shUBS Group AG
$5.9K4,248 shTower Research Capital LLC (TRC)
$4.9K3,527 shVANGUARD CAPITAL MANAGEMENT LLC
$4.4K3,217 shBlackRock, Inc.
$1.5K1,093 shSBI Securities Co., Ltd.
$530.00384 shWELLS FARGO & COMPANY/MN
$43.0031 shVirtu Financial LLC
$14.0010,478 sh
| Fund | Value | Shares |
|---|---|---|
| ARMISTICE CAPITAL, LLC | $371.6K | 269,253 |
| GEODE CAPITAL MANAGEMENT, LLC | $49.8K | 36,076 |
| VANGUARD FIDUCIARY TRUST CO | $7.0K | 5,068 |
| UBS Group AG | $5.9K | 4,248 |
| Tower Research Capital LLC (TRC) | $4.9K | 3,527 |
| VANGUARD CAPITAL MANAGEMENT LLC | $4.4K | 3,217 |
| BlackRock, Inc. | $1.5K | 1,093 |
| SBI Securities Co., Ltd. | $530.00 | 384 |
| WELLS FARGO & COMPANY/MN | $43.00 | 31 |
| Virtu Financial LLC | $14.00 | 10,478 |
More Healthcare Companies
View all Healthcare →Put GOVX on your watchlist
Track score changes the day GeoVax Labs, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is GOVX a good stock to buy?
13F Pro's AI-powered analysis of GeoVax Labs, Inc. (GOVX) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for GOVX are available on the GOVX stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own GOVX?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling GOVX. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of GeoVax Labs, Inc.'s investment landscape.